A Current Appraisal of Drug Therapy of Atherosclerosis

References

• Moses , C. 1963 . Atherosclerosis: Mechanisms as a Guide to Prevention , 11 – 13 . Philadelphia : Lea & Febiger, Publisher .
   Google Scholar
• Lew , E.A. 1957 . Some Implications of Mortality Statistics Relating to Coronary Artery Disease . J Chronic Dis , 6 : 192 – 209 .
   PubMedGoogle Scholar
• Beem , J.R. 1959 . “ Causes of Death Due to Hypertension: The Effect of Therapy ” . In Hypertension , Edited by: Moyer , J.H. 106 – 111 . Philadelphia : W. B. Saunders Company . in
   Google Scholar
• et al. Substituted Aminoalkoxy Triarylethanols and Their Derivatives Proceedings of the 134th Meeting of the American Chemical Society Proceedings of the 134th Meeting of the American Chemical Society Chicago Proceedings of the 134th Meeting of the American Chemical Society Chicago Sept 1958 12 Section O
   Google Scholar
• Blohm , T.R. and MacKenzie , R.D. 1959 . Specific Inhibition of Cholesterol Biosynthesis by a Synthetic Compound (MER-29) . Arch Biochem , 85 : 245 – 249 .
   PubMed Web of Science ®Google Scholar
• Blohm , T.R. , Kariya , T. and McLaughlin , M.W. 1959 . Effects of MER-29, a Cholesterol Synthesis Inhibitor, on Mammalian Tissue Lipides . Arch Biochem , 85 : 250 – 263 .
   PubMed Web of Science ®Google Scholar
• Steinberg , D. , Avigan , J. and Feigelson , E.B. 1959 . Identification of 24-Dehydrocholesterol in the Serum of Patients Treated With MER-29 . Prog Cardiov Dis , 2 : 586 – 592 .
   Web of Science ®Google Scholar
• Hollander , W. , Chobanian , A.V. and Wilkins , R.W. 1960 . Effects of Triparanol (MER-29) in Subjects With and Without Coronary Artery Disease . JAMA , 174 : 5 – 12 .
   PubMed Web of Science ®Google Scholar
• Oaks , W. , Lisan , P. and Moyer , J.H. 1959 . Inhibition of Cholesterol Synthesis With the Use of MER-29 . Arch Intern Med , 104 : 527 – 531 .
   PubMed Web of Science ®Google Scholar
• Furman , R.H. and Robinson , C.W. 1951 . Hypocholesterolemic Agents . Med Clin N Amer , 45 July : 935 – 959 .
   Google Scholar
• Berkowitz , D. , Likoff , W. and Sklaroff , D.M. 1959 . The Effect of Sitosterol on Radioactive Fat Absorption Patterns . Amer Cardiol , 4 : 282 – 286 .
   Web of Science ®Google Scholar
• Korn , E.D. 1955 . Clearing Factor, a Heparin-Activated Lipoprotein Lipase: I. Isolation and Characterization of the Enzyme From Normal Rat Heart . J Biol Chem , 215 : 1 – 14 .
   PubMed Web of Science ®Google Scholar
• et al. Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-Up Experience: The Framingham Study Ann Intern Med 1961 55 33 50
   PubMed Web of Science ®Google Scholar
• et al. Effectiveness of Estrogens for the Long-Term Therapy of Middle-Aged Men With a History of Myocardial Infarction Coronary Heart Disease Likoff W. Moyer J.H. Grune & Stratton Inc. New York 1963 416 435 in
   Google Scholar
• et al. Effect of Premarin on Survival in Men With Myocardial Infarction Proc Soc Exp Biol Med Nov-Dec 1960 105 618 620
   PubMed Web of Science ®Google Scholar
• et al. Clinical Studies of Long-Term Therapy in Men With Myocardial Infarction Proc Soc Exp Biol Med 1962 110 400 408
   PubMed Web of Science ®Google Scholar